Publications de Christel PROTIERE
Primary tabs
Acceptability of public health information and prevention measures by gay men, bisexual men and men who have sex with men during the French Mpox outbreak in 2022: the ANRS-MPX-SHS cross-sectional survey.
Sexually Transmitted Infections
2026
;
102
(1)
:
36-42.
Willingness to participate in a long-acting injectable cabotegravir HIV pre-exposure prophylaxis study among men who have sex with men in the French ANRS-PREVENIR cohort.
Sexually Transmitted Infections
2025
;
sextrans-2025-056662.
Structural factors associated with viral suppression among transgender women living with HIV in France.
AIDS. Official journal of the international AIDS Society
2025
.
Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction services.
Substance Abuse Treatment, Prevention, and Policy
2025
;
20
(1)
:
33.
The sociodynamics of chemsex: Stakeholders’ perspectives in France - Results from the ANRS-PaacX study.
SSM - Qualitative Research in Health
2025
;
7
:
100542.
“They Have to Make an Effort Too”: What Decliners Can Teach Us About HIV Cure/Remission-Related Clinical Trials? Results from a French Qualitative Study.
AIDS Research and Human Retroviruses
2025
;
41
(1)
:
20-29.
Trajectories of Chemsex Engagement Across Time Among PrEP-Using Men Who Have Sex with Men: Results from the French ANRS-Prévenir Cohort.
International Journal of Sexual Health
2025
;
37
(3)
:
1-22.
https://www.tandfonline.com/doi/full/10.1080/19317611.2025.2511902
Diversity of Chemsex Experiences among Men Who Have Sex with Men: Results from the French ANRS PaacX Study Using Q-Methodology.
Archives of Sexual Behavior
2024
.
Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort.
HIV Medicine
2023
;
24
:
938 - 945.
Impact of HIV risk perception on both pre-exposure prophylaxis and condom use.
Journal of Health Psychology
2021
;
26
(10)
:
1575-1586.
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment.
Journal of the International AIDS Society
2020
;
23
(2)
:
e25443.
What are the situational and behavioral factors associated with condomless anal sex without pre-exposure prophylaxis in MSM?
AIDS. Official journal of the international AIDS Society
2020
;
34
(9)
:
1367-1375.
Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?
AIDS. Official journal of the international AIDS Society
2020
;
1.
What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study.
Journal of Virus Eradication
2019
;
5
(3)
:
152-162.
The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the “participant”-physician relationship.
AIDS Care
2018
;
30
(sup2)
:
41-47.
Importance of the patient-physician interaction in assessing acceptability of HIV cure trials.
HIV Medicine
2018
;
19
(4)
:
e56-e57.
Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC).
AIDS Care
2018
;
30
(7)
:
914-920.
Will CURE trials introduce an uncomfortable revolution in the field of HIV research?
HIV Clinical Trials
2017
;
18
(4)
:
174-175.
https://www.tandfonline.com/doi/full/10.1080/15284336.2017.1331603
How Can Contingent Valuation Inform the Bioethics Debate? Evidence from a Survey on Hereditary Cancers in France.
Revue Economique
2017
;
68
(3)
:
379--404.
Take the Money and Run? Hypothetical Fee Variations and French GPs’ Labour Supply.
Revue Economique
2017
;
68
(3)
:
357--377.
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study.
Annals of Oncology
2010
;
21
(7)
:
1448-1454.
Préférences des femmes pour une réduction de l’hospitalisation après chirurgie conservatrice pour tumeur mammaire : faisabilité, profil et satisfaction des patientes.
Annales de Chirurgie
2003
;
128
(1)
:
26-33.
Eliciting several willingness to pay in a single contingent valuation survey: application to health care.
Health Economics
2003
;
12
(1)
:
51-64.
Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Supportive Care in Cancer
2002
;
10
(7)
:
529-537.
Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles.
Supportive Care in Cancer
2002
;
10
(3)
:
222-230.
Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer.
Annals of Oncology
2000
;
11
(1)
:
39-46.
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancer.
European Cytokine Network
1998
;
9
(1)
:
93-98.
Evaluation économétrique du coût d'une allogreffe de moelle osseuse.
Journal d'Economie Médicale
1996
;
14
(6)
:
323-331.